Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

About 20% of patients with a history of atherosclerotic cardiovascular disease will experience further cardiovascular events despite maximal pharmacological treatment with cardioprotective drugs. This highlights the presence of residual cardiovascular risk in a significant proportion of patients and...

Full description

Bibliographic Details
Main Authors: Arduino A Mangoni, Sara Tommasi, Angelo Zinellu, Salvatore Sotgia, Ciriaco Carru, Matteo Piga, Gian Luca Erre
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2018-11-01
Series:Drugs in Context
Subjects:
arterial function
atherosclerosis
blood pressure
cardiovascular risk
inflammation
methotrexate
repurposing
Online Access:https://www.drugsincontext.com/repurposing-existing-drugs-for-cardiovascular-risk-management-a-focus-on-methotrexate

Internet

https://www.drugsincontext.com/repurposing-existing-drugs-for-cardiovascular-risk-management-a-focus-on-methotrexate

Similar Items